Dowiedzieć się o najlepszych cenach i klinikach w leczeniu stwardnienia rozsianego komórkami macierzystymi w Tajlandii w 2026 roku

Thailand's Ministry of Public Health regulates stem cell treatments for multiple sclerosis. Leading centres use AABB-certified laboratories and mesenchymal stem cells (MSCs). These therapies are experimental but performed by board-certified specialists. Facilities like ID Clinic Bangkok treat over 4,000 patients annually.

• Regulatory oversight: The Ministry of Public Health sanctions specific clinics for allogeneic stem cell therapies.
• Laboratory standards: Quality providers use AABB-certified processes for culturing and activating umbilical cord cells.
• Specialist credentials: Doctors like Dr Chollawat Thongthaisin hold American Board of Regenerative Medicine certification.
• Cellular protocols: Clinics typically administer specific doses, ranging from 80 million to 150 million MSCs.

Bookimed Expert Insight: Data shows a major difference between basic aesthetic clinics and dedicated regenerative centres. Specialists at Vega Clinic provide precise MSC dosages (80M–150M cells) rather than vague "sessions". Choosing a clinic with on-site AABB-certified labs helps cell viability remain high during the procedure.

Patient Consensus: Success varies globally. Patients suggest verifying cell passage numbers and sterility controls before booking in Thailand. Practical travellers recommend confirming if airport transfers and hospital stays are bundled to simplify the medical holiday experience.

Stem cell treatment in Thailand does not cure multiple sclerosis (MS). Clinics in Bangkok and Phuket offer therapies to manage symptoms or slow disease progression. Most facilities use mesenchymal stem cell (MSC) infusions. This differs from the more intensive haematopoietic stem cell transplantation (HSCT) found in hospitals.

• Treatment goals: Therapy aims to halt progression or reduce relapses rather than providing a cure.
• Cell types: Clinics typically use umbilical cord-derived mesenchymal stem cells (MSCs) for intravenous infusions.
• Regulatory status: The Thailand Health Ministry has sanctioned specific clinics, such as The Demarest Clinic, for allogeneic therapy.
• Dosing options: Typical packages at specialised centres like Vega Clinic offer doses between 80 million and 150 million MSCs.

Bookimed Expert Insight: Many international clinics offer basic infusions. However, reliable Thai centres invest in high-level cell processing. The Demarest Clinic in Phuket holds AABB (American Association of Blood Banks) certification for its cell protocols. This means the infused cells meet international standards for viability and safety. This is a critical factor for MS patients seeking cellular therapy.

Patient Consensus: Reports in Thailand suggest patients focus on symptom improvement and relapse control. They generally do not expect a full reversal of MS. People recommend verifying clinic credibility and checking for quality certifications before booking experimental treatments.

Thailand clinics primarily use allogeneic Mesenchymal Stem Cells (MSCs) from birth tissues like umbilical cord and placenta. These providers use intravenous infusions of 80 million to 150 million MSCs. This helps modulate the immune system and reduce neuroinflammation.

• Mesenchymal Stem Cells: Clinics use MSCs from umbilical cord tissue or Wharton’s Jelly for anti-inflammatory effects.
• Allogeneic Sources: Most Thai providers specialise in donor-derived cells rather than the patient’s own tissue.
• Cellular Combinations: The Demarest Clinic in Phuket combines umbilical cord MSCs with amniotic fluid-based therapy.
• IV Infusions: Doctors typically deliver these high-dose cellular treatments via intravenous infusion over several days.

Bookimed Expert Insight: Thai centres now prioritise first-passage MSCs to maintain higher cellular potency. Protocols at places like The Demarest Clinic use AABB-certified processes. These processes verify that cells are activated correctly before infusion. Patients should check if their A$48,800 to A$84,400 package includes these laboratory certifications.

Patient Consensus: Patients in Thailand often receive donor birth-tissue MSCs via IV. Many suggest confirming if the protocol involves chemotherapy-based immune resetting or simple cell infusions. Professional coordinators help clarify these differences. They also manage the 4–6 day hospital stays required for treatment.

Specialists in Thailand administer umbilical cord mesenchymal stem cells (MSCs) primarily via intravenous infusion or intrathecal injection. Treatment at centres like Vega Clinic and The Demarest Clinic involves a multi-day stay. This allows for doses often ranging from 80 million to 150 million cells.

• Intravenous infusion: Delivers stem cells directly into the bloodstream to modulate the immune system.
• Intrathecal injection: Bypasses the blood-brain barrier by injecting cells into the cerebrospinal fluid.
• Allogeneic therapy: Uses donor cells, such as umbilical cord or amniotic fluid-derived mesenchymal stem cells.
• Supportive care: Clinics like Vega Clinic provide airport transfers and inpatient stays for 4–6 days.

Bookimed Expert Insight: Data suggests a link between MSC dosage and stay duration in Thai clinics. A standard 80 million cell dose requires a 4-day hospital stay. The intensive 150 million cell protocol at Vega Clinic requires 6 days. This helps medical teams monitor patient responses to higher cellular concentrations.

Patient Consensus: Patients in Thailand often report receiving a mix of IV and spinal injections. They recommend confirming cell sources. They also suggest checking that the delivery route is written into the treatment contract.

Multiple sclerosis stem cell programs in Thailand typically require a stay of 7 to 14 days. Patients spend 4 to 6 days in the clinic for medical evaluations and cellular infusions. A further week is recommended for monitoring before flying back to Australia.

• Hospital phase: Patients spend 4–6 days in clinic for infusions and neurological monitoring.
• Clinical protocols: Doctors like Dr Chollawat Thongthaisin use 80 to 150 million mesenchymal stem cells.
• Evaluation time: Detailed assessments and scans often require 2–3 days before treatment begins.
• Total trip: Most international programs suggest 14 days on-site for safe travel.

Bookimed Expert Insight: Thailand offers stem cell access through specialised centres like The Demarest Clinic. This was the first facility sanctioned by the Health Ministry for allogeneic therapy. While packages often include VIP airport transfers, they rarely cover the recommended 7–14 days of hotel accommodation. Patients save approximately 53% compared to Australian costs, even when self-funding these external stays.

Patient Consensus: Programs are delivered as intensive clinic visits rather than long hospital admissions. People found that planning for two weeks on the ground allowed enough time for thorough assessments and post-treatment recovery.

Multiple sclerosis stem cell packages in Thailand generally include mesenchymal stem cell (MSC) dosing, specialist consultations, and airport transfers. Most protocols cover a 4–6 day hospital stay for administration. Patients often save up to 37% compared to the $55,500 average cost in Australia.

• Stem cell dosage: Packages specify MSC counts. These typically range from 80 million to 150 million cells.
• Medical consultations: Includes initial neurology reviews and sessions with American Board-certified regenerative doctors.
• Inpatient stay: Standard packages bundle 4–6 days in a hospital room during treatment cycles.
• Logistics support: Includes VIP airport-hotel-clinic transfers to help patients with mobility challenges.

Bookimed Expert Insight: A common trap for Australian patients is misinterpreting hotel listings. Many Thai packages require a 7–14 night stay for monitoring. However, they often exclude the cost of the hotel itself. Vega Clinic, which serves 200+ international patients yearly, follows this model. Always check if hotel fees are included or just a recommended duration.

Patient Consensus: Patients value the bundled transfers and hospital stays that simplify travel. Most confirm that kits cover basic blood tests and specialist reviews. Many recommend confirming if post-discharge follow-ups in Australia are included.